Vultaggio-Poma V - Search Results

1

The Purinergic Landscape of Type 2 Diabetes Mellitus.

Garcia-Jacobo RE, Bergamin LS, Vultaggio-Poma V, Thorstenberg ML, Tarantini M, García-Hernández MH, Di Virgilio F. Garcia-Jacobo RE, et al. Among authors: vultaggio poma v. Molecules. 2022 Mar 11;27(6):1838. doi: 10.3390/molecules27061838. Molecules. 2022. PMID: 35335211 Free PMC article. Review.

2

Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation.

Di Virgilio F, Giuliani AL, Vultaggio-Poma V, Falzoni S, Sarti AC. Di Virgilio F, et al. Front Pharmacol. 2018 Feb 1;9:39. doi: 10.3389/fphar.2018.00039. eCollection 2018. Front Pharmacol. 2018. PMID: 29449813 Free PMC article. Review.

3

Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine.

Chiozzi P, Sarti AC, Sanz JM, Giuliani AL, Adinolfi E, Vultaggio-Poma V, Falzoni S, Di Virgilio F. Chiozzi P, et al. Sci Rep. 2019 Apr 24;9(1):6475. doi: 10.1038/s41598-019-42931-2. Sci Rep. 2019. PMID: 31019207 Free PMC article.

4

The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels.

Giuliani AL, Berchan M, Sanz JM, Passaro A, Pizzicotti S, Vultaggio-Poma V, Sarti AC, Di Virgilio F. Giuliani AL, et al. Front Immunol. 2019 Apr 12;10:793. doi: 10.3389/fimmu.2019.00793. eCollection 2019. Front Immunol. 2019. PMID: 31031771 Free PMC article.

5

Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.

Di Virgilio F, Jiang LH, Roger S, Falzoni S, Sarti AC, Vultaggio-Poma V, Chiozzi P, Adinolfi E. Di Virgilio F, et al. Methods Enzymol. 2019;629:115-150. doi: 10.1016/bs.mie.2019.07.043. Epub 2019 Sep 3. Methods Enzymol. 2019. PMID: 31727237

6

Extracellular ATP: A Feasible Target for Cancer Therapy.

Vultaggio-Poma V, Sarti AC, Di Virgilio F. Vultaggio-Poma V, et al. Cells. 2020 Nov 17;9(11):2496. doi: 10.3390/cells9112496. Cells. 2020. PMID: 33212982 Free PMC article. Review.

7

P2X receptors in cancer growth and progression.

Di Virgilio F, Vultaggio-Poma V, Sarti AC. Di Virgilio F, et al. Biochem Pharmacol. 2021 May;187:114350. doi: 10.1016/j.bcp.2020.114350. Epub 2020 Nov 28. Biochem Pharmacol. 2021. PMID: 33253643 Review.

8

P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy.

Sarti AC, Vultaggio-Poma V, Di Virgilio F. Sarti AC, et al. Purinergic Signal. 2021 Jun;17(2):175-178. doi: 10.1007/s11302-021-09783-w. Epub 2021 Apr 5. Purinergic Signal. 2021. PMID: 33818742 Free PMC article. Review. No abstract available.

9

Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation.

Vultaggio-Poma V, Falzoni S, Chiozzi P, Sarti AC, Adinolfi E, Giuliani AL, Sánchez-Melgar A, Boldrini P, Zanoni M, Tesei A, Pinton P, Di Virgilio F. Vultaggio-Poma V, et al. Theranostics. 2022 Jan 1;12(2):859-874. doi: 10.7150/thno.66274. eCollection 2022. Theranostics. 2022. PMID: 34976217 Free PMC article.

10

Signalling by extracellular nucleotides in health and disease.

Vultaggio-Poma V, Falzoni S, Salvi G, Giuliani AL, Di Virgilio F. Vultaggio-Poma V, et al. Biochim Biophys Acta Mol Cell Res. 2022 May;1869(5):119237. doi: 10.1016/j.bbamcr.2022.119237. Epub 2022 Feb 9. Biochim Biophys Acta Mol Cell Res. 2022. PMID: 35150807 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page